Literature DB >> 16424867

High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia.

M R Mansour, D C Linch, L Foroni, A H Goldstone, R E Gale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16424867     DOI： 10.1038/sj.leu.2404101

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  21 in total

1.  Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL.

Authors:  Wendy R Gordon; Monideepa Roy; Didem Vardar-Ulu; Megan Garfinkel; Marc R Mansour; Jon C Aster; Stephen C Blacklow
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

2.  Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer.

Authors:  Giovanni Roti; Anne Carlton; Kenneth N Ross; Michele Markstein; Kostandin Pajcini; Angela H Su; Norbert Perrimon; Warren S Pear; Andrew L Kung; Stephen C Blacklow; Jon C Aster; Kimberly Stegmaier
Journal:  Cancer Cell       Date:  2013-02-21       Impact factor: 31.743

Review 3.  Effects of Toll-like receptor signals in T-cell neoplasms.

Authors:  Cori Morrison; Maria R Baer; Dan P Zandberg; Amy Kimball; Eduardo Davila
Journal:  Future Oncol       Date:  2011-02       Impact factor: 3.404

4.  Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.

Authors:  Noémi Nagy; Melinda Hajdu; Ágnes Márk; Péter Attila Király; Mónika Tóth; Titanilla Dankó; Mónika Csóka; Anna Sebestyén
Journal:  Tumour Biol       Date:  2016-07-29

5.  Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression.

Authors:  Sankaranarayanan Kannan; Wendy Fang; Guangchun Song; Charles G Mullighan; Richard Hammitt; John McMurray; Patrick A Zweidler-McKay
Journal:  Blood       Date:  2011-01-11       Impact factor: 22.113

6.  Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma.

Authors:  Daisuke Shimizu; Tomohiko Taki; Atae Utsunomiya; Hitoshi Nakagawa; Kenichi Nomura; Yosuke Matsumoto; Kazuhiro Nishida; Shigeo Horiike; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

7.  Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.

Authors:  V Agnusdei; S Minuzzo; C Frasson; A Grassi; F Axelrod; S Satyal; A Gurney; T Hoey; E Seganfreddo; G Basso; S Valtorta; R M Moresco; A Amadori; S Indraccolo
Journal:  Leukemia       Date:  2013-06-18       Impact factor: 11.528

8.  Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.

Authors:  Marc R Mansour; Maria L Sulis; Veronique Duke; Letizia Foroni; Sarah Jenkinson; Kenneth Koo; Christopher G Allen; Rosemary E Gale; Georgina Buck; Sue Richards; Elisabeth Paietta; Jacob M Rowe; Martin S Tallman; Anthony H Goldstone; Adolfo A Ferrando; David C Linch
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

9.  The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia.

Authors:  Teresa Palomero; Maria Dominguez; Adolfo A Ferrando
Journal:  Cell Cycle       Date:  2008-02-19       Impact factor: 4.534

10.  The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  A Larson Gedman; Q Chen; S Kugel Desmoulin; Y Ge; K LaFiura; C L Haska; C Cherian; M Devidas; S B Linda; J W Taub; L H Matherly
Journal:  Leukemia       Date:  2009-04-02       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.